Study of HS-10241 in Combination With Almonertinib in Patients With Locally Advanced or Metastatic NSCLC
Clinical trial NCT05430386 · UNKNOWN
Trial details
- NCT number
- NCT05430386
- Sponsor
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-05
- Primary completion
- 2023-12-31
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.